ReviewFoods (Basel, Switzerland)2025
Omics Insights into Cylindrospermopsin's Molecular Toxicity.
Review in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cylindrospermopsin (CYN) is a potent cyanotoxin that poses a significant risk to human and animal health. Due to its occurrence in drinking water and food, as well as its ability to bioaccumulate in aquatic organisms and plants irrigated with contaminated water, the oral route is an important exposure pathway. However, data gaps in the current toxicological data for CYN jeopardize the establishment of health guidance values. In this context, mechanistic data and a deeper knowledge of CYN's mode of action and its adverse outcome pathways are priorities for risk assessment. In recent years, omics techniques have enabled important advances in the comprehensive characterization of the molecular toxicity of CYN. In vitro studies have mainly focused on liver and kidney models, while in vivo studies have mostly used aquatic organisms. These studies have shown effects at both the transcriptional and protein levels on various signaling pathways related to detoxification, DNA damage, apoptosis, cell survival, and lipid metabolism, among others. However, studies using lipidomic, metabolomic, or microbiomic techniques are limited to date. Nevertheless, a recent study suggests that CYN may also induce gut dysbiosis, which would further extend its toxicological profile. This review emphasizes the need to further expand the use of omics approaches to accurately assess the risks associated with the consumption of CYN-contaminated foods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.